Please enable JS

Investors & Media

2018 News Releases

Keyword Search
 
2018 | 2017 | 2016 | 2015 | 2014
DateTitle 
Jan-04-2018CRISPR Therapeutics Announces Pricing of Public Offering of Common Shares
ZUG, Switzerland and CAMBRIDGE, Mass., Jan. 04, 2018 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq:CRSP), a biopharmaceutical company focused on developing transformative gene-based medicines for serious diseases, today announced the pricing of an underwritten public offering of 5,000,000 of its common shares at a public offering price of $22.75 per share, before underwriting discounts. In addition, CRISPR Therapeutics has granted the underwriters a 30-day option to purchase up to an additio... 
Printer Friendly Version
Jan-03-2018CRISPR Therapeutics Announces Proposed Public Offering of Common Shares
ZUG, Switzerland and CAMBRIDGE, Mass., Jan. 03, 2018 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq:CRSP), a biopharmaceutical company focused on developing transformative gene-based medicines for serious diseases, today announced that it is commencing an underwritten public offering of $100,000,000 of its common shares. In addition, CRISPR Therapeutics expects to grant the underwriters a 30-day option to purchase up to an additional $15,000,000 of its common shares in connection with the pub... 
Printer Friendly Version
Print Page E-mail Page RSS Feeds E-mail Alerts IR Contacts Financial Tear Sheet